Role of ceramide in the physiology and pathophysiology of nervous systems

Advances in Neuroimmune Biology

Volumn 4, Issue 1, 2013, Pages 35-44

  Hossain, Md Shamim ^a   Ifuku, Masataka ^a   Katafuchi, Toshihiko ^a  

^a KYUSHU UNIVERSITY   (Japan)

Author keywords

action potentials; apoptosis; Ceramide; cytokines; inflammation

Indexed keywords

ACTIVATING TRANSCRIPTION FACTOR 4; ALPHA AMINO 3 HYDROXY 5 METHYL 4 ISOXAZOLEPROPIONIC ACID; CERAMIDE; CYTOCHROME C; GLYCOGEN SYNTHASE KINASE 3BETA; GROWTH ARREST AND DNA DAMAGE INDUCIBLE PROTEIN 153; HYPOXIA INDUCIBLE FACTOR 1ALPHA; INTERLEUKIN 1BETA; N METHYL DEXTRO ASPARTIC ACID; SPHINGOMYELIN; SPHINGOMYELIN PHOSPHODIESTERASE; VASCULOTROPIN;

ALZHEIMER DISEASE; APOPTOSIS; ARTICLE; CELL MIGRATION; CELL ORGANELLE; DISEASE COURSE; ELECTROPHYSIOLOGY; ENDOPLASMIC RETICULUM; ENZYME ACTIVITY; ENZYME INDUCTION; ENZYME RELEASE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; LIPID METABOLISM; LIPID RAFT; LIPOGENESIS; LONG TERM POTENTIATION; MITOCHONDRION; NERVE CELL NECROSIS; NEUROLOGIC DISEASE; NONHUMAN; OLIGODENDROGLIA; OXIDATIVE STRESS; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION; UPREGULATION;

EID: 84880230086     PISSN: 1878948X     EISSN: 18789498     Source Type: Journal    
DOI: 10.3233/NIB-130055     Document Type: Article

References (113)

1. Zeidan YH, Hannun YA. Translational aspects of sphingolipid metabolism.Trends Mol Med. 2007; 138: 327-336.
2. Hannun YA, Obeid LM. Principles of bioactive lipid signalling: Lessons from sphingolipids. Nat RevMol Cell Biol. 2008; 92: 139-150.
3. Bartke N, HannunY A. Bioactive sphingolipids: Metabolism and function. J Lipid Res. 2009; 50Suppl.: S91-S96.
4. Kitatani K, Idkowiak-Baldys J, Hannun YA. The sphingolipid salvage pathway in ceramide metabolism and signaling. Cell Signal. 2008; 206: 1010-1018.
5. Kemper AR, Knapp AA, Green NS, Comeau AM, Metterville DR, Perrin JM. Weighing the evidence for newborn screening for early-infantile Krabbe disease. Genet Med. 2010; 129: 539-543.
6. Galjaard H, Hoogeveen A, de Wit-Verbeek HA, Reuser AJ, Ho MW, Robinson D. Genetic heterogeneity in GM1-gangliosidosis. Nature. 1975; 2575521: 60-62.
7. Kanzaki S, Yamaguchi A, Yamaguchi K, Kojima Y, Suzuki K, Koumitsu N, et al. Thymic alterations in GM2 gangliosidoses model mice. PLoS One. 2010; 58.
8. Max SR, Maclaren NK, Brady RO, Bradley RM, Rennels MB, Tanaka J, et al. GM3 hematoside sphingolipodystrophy. N Engl J Med. 1974; 29118: 929-931.
9. Nagueh SF. Fabry disease. Heart. 2003; 898: 819-820.
10. Goldfinger M, Laviad EL, Hadar R, Shmuel M, Dagan A, Park H, et al. De novo ceramide synthesis is required for N-linked glycosylation in plasma cells. J Immunol. 2009; 18211: 7038-7047.
11. Stiban J, Caputo L, Colombini M. Ceramide synthesis in the endoplasmic reticulum can permeabilize mitochondria to proapoptotic proteins. J Lipid Res. 2008; 493: 625-634.
12. Hanada K, Kumagai K, Tomishige N, Kawano M. CERT and intracellular trafficking of ceramide. Biochim Biophys Acta. 2007; 17716: 644-653.
13. Wyles JP, Perry RJ, Ridgway ND. Characterization of the sterol-binding domain of oxysterol-binding protein OSBP-related protein 4 reveals a novel role in vimentin organization. Exp Cell Res. 2007; 3137: 1426-1437.
14. Chandran S, Machamer CE. Acute perturbations in Golgi organization impact de novo sphingomyelin synthesis. Traffic. 2008; 911: 1894-1904.
15. Charruyer A, Bell SM, Kawano M, Douangpanya S, Yen TY, Macher BA, et al. Decreased ceramide transport protein CERT function alters sphingomyelin production following UVBirradiation. J Biol Chem. 2008; 28324: 16682-16692.
16. Hullin-Matsuda F, Tomishige N, Sakai S, Ishitsuka R, Ishii K, Makino A, et al. Limonoid compounds inhibit sphingomyelin biosynthesis by preventing CERT proteindependent extraction of ceramides from the endoplasmic reticulum. J Biol Chem. 2012; 28729: 24397-24411.
17. Lannert H, Gorgas K, Meissner I, Wieland FT, Jeckel D. Functional organization of the Golgi apparatus in glycosphingolipid biosynthesis. Lactosylceramide and subsequent glycosphingolipids are formed in the lumen of the late Golgi. J Biol Chem. 1998; 2735: 2939-2946.
18. Marza E, Simonsen KT, Faergeman NJ, Lesa GM. Expression of ceramide glucosyltransferases, which are essential for glycosphingolipid synthesis, is only required in a small subset of C. elegans cells. J Cell Sci. 2009; 122Pt 6: 822-833.
19. Linn SC, Kim HS, Keane EM, Andras LM,Wang E, Merrill AH Jr. Regulation of de novo sphingolipid biosynthesis and the toxic consequences of its disruption. Biochem SocTrans. 2001; 29Pt 6: 831-835.
20. Taieb N, Yahi N, Fantini J. Rafts and related glycosphingolipid-enriched microdomains in the intestinal epithelium: Bacterial targets linked to nutrient absorption. Adv Drug Deliv Rev. 2004; 566: 779-794.
21. Puryear WB, Gummuluru S. Role of glycosphingolipids in dendritic cell-mediated HIV-1 trans-infection. Adv Exp Med Biol. 2013; 762: 131-153.
22. Rozenova KA, Deevska GM, Karakashian AA, Nikolova-Karakashian MN. Studies on the role of acid sphingomyelinase and ceramide in the regulation of tumor necrosis factor-TNF-converting enzyme activity and TNF-secretion in macrophages. J Biol Chem. 2010; 28527: 21103-21113.
23. Segui B, Bezombes C, Uro-Coste E, Medin JA, Andrieu-Abadie N, Auge N, et al. Stress-induced apoptosis is not mediated by endolysosomal ceramide. FASEB J. 2000; 141: 36-47.
24. Fyrst H, Saba JD. An update on sphingosine-1-phosphate and other sphingolipid mediators. Nat Chem Biol. 2010; 67: 489-497.
25. Kirkegaard T, Jaattela M. Lysosomal involvement in cell death and cancer. Biochim Biophys Acta. 2009; 17934: 746-754.
26. Ullio C, Casas J, Brunk UT, Sala G, Fabrias G, Ghidoni R, et al. Sphingosine mediates TNF-induced lysosomal membrane permeabilization and ensuing programmed cell death in hepatoma cells. J Lipid Res. 2012; 536: 1134-1143.
27. Ardail D, Popa I, Alcantara K, Pons A, Zanetta JP, Louisot P, et al. Occurrence of ceramides and neutral glycolipids with unusual long-chain base composition in purified rat liver mitochondria. FEBS Lett. 2001; 4883: 160-164.
28. Tserng KY, Griffin R. Quantitation and molecular species determination of diacylglycerols, Phosphatidylcholines, ceramides, and sphingomyelins with gas chromatography. Anal Biochem. 2003; 3231: 84-93.
29. Siskind LJ. Mitochondrial ceramide and the induction of apoptosis. J Bioenerg Biomembr. 2005; 373: 143-153.
30. Siskind LJ, Kolesnick RN, Colombini M. Ceramide forms channels in mitochondrial outer membranes at physiologically relevant concentrations. Mitochondrion. 2006; 63: 118-125.
31. Zhang YH, Vasko MR, Nicol GD. Ceramide, a putative second messenger for nerve growth factor, modulates the TTX-resistant Na+ current and delayed rectifier K+ current in rat sensory neurons. J Physiol. 2002; 544Pt 2: 385-402.
32. Fasano C, Terce F, Niel JP, Nguyen TT, Hiol A, Bertrand-Michel J, et al. Neuronal conduction of excitation without action potentials based on ceramide production. PLoS One. 2007; 27: e612.
33. Fasano C, Miolan JP, Niel JP. Modulation by C2 ceramide of the nicotinic transmission within the coeliac ganglion in the rabbit. Neuroscience. 2003; 1163: 753-759.
34. Fasano C, Niel JP. The mammalian sympathetic prevertebral ganglia: Models for the study of neuronal networks and basic neuronal properties. Auton Neurosci. 2009; 1501-2: 8-20.
35. Coogan AN, O'Neill LA, O'Connor JJ. The P38 mitogenactivated protein kinase inhibitor SB203580 antagonizes the inhibitory effects of interleukin-1-on long-term potentiation in the rat dentate gyrus in vitro. Neuroscience. 1999; 931: 57-69.
36. Maalouf M, Rho JM. Oxidative impairment of hippocampal long-term potentiation involves activation of protein phosphatase 2A and is prevented by ketone bodies. J Neurosci Res. 2008; 8615: 3322-3330.
37. Ramstrom C, Chapman H, Ekokoski E, Tuominen RK, Pasternack M, Tornquist K. Tumor necrosis factor-and ceramide depolarise the resting membrane potential of thyroid FRTL-5 cells via a protein kinase Czeta-dependent regulation of K+ channels. Cell Signal. 2004; 1612: 1417-1424.
38. Hida H, Takeda M, Soliven B. Ceramide inhibits inwardly rectifyingK+ currents via a Ras-and Raf-1-dependent pathway in cultured oligodendrocytes. J Neurosci. 1998; 1821: 8712-8719.
39. Montes LR, Ruiz-Arguello MB, Goni FM, Alonso A. Membrane restructuring via ceramide results in enhanced solute efflux. J Biol Chem. 2002; 27714: 11788-11794.
40. Sot J, Bagatolli LA, Goni FM, Alonso A. Detergentresistant, Ceramide-enriched domains in sphingomyelin/ceramide bilayers. Biophys J. 2006; 903: 903-914.
41. Silva LC, Almeidade RF, Castro BM, Fedorov A, Prieto M. Ceramide-domain formation and collapse in lipid rafts: Membrane reorganization by an apoptotic lipid. Biophys J. 2007; 922: 502-516.
42. Megha, London E. Ceramide selectively displaces cholesterol from ordered lipid domains rafts: Implications for lipid raft structure and function. J Biol Chem. 2004; 27911: 9997-10004.
43. Besshoh S, Chen S, Brown IR, Gurd JW. Developmental changes in the association of NMDA receptors with lipid rafts. J Neurosci Res. 2007; 859: 1876-1883.
44. Hering H, Lin CC, Sheng M. Lipid rafts in the maintenance of synapses, dendritic spines, and surface AMPA receptor stability. J Neurosci. 2003; 238: 3262-3271.
45. Pani B, Singh BB. Lipid rafts/caveolae as microdomains of calcium signaling. Cell Calcium. 2009; 456: 625-633.
46. Maguy A, Hebert TE, Nattel S. Involvement of lipid rafts and caveolae in cardiac ion channel function. Cardiovasc Res. 2006; 694: 798-807.
47. Ifuku M, Katafuchi T, Mawatari S, Noda M, Miake K, Sugiyama M, et al. Anti-inflammatory/anti-amyloidogenic effects of plasmalogens in lipopolysaccharide-induced neuroinflammation in adult mice. J Neuroinflammation. 2012; 9: 197.
48. Hildt E, Oess S. Identification of Grb2 as a novel binding partner of tumor necrosis factor TNF receptor I. J Exp Med. 1999; 18911: 1707-1714.
49. Silva LC, Futerman AH, Prieto M. Lipid raft composition modulates sphingomyelinase activity and ceramide-induced membrane physical alterations. Biophys J. 2009; 968: 3210-3222.
50. Chen CL, Lin CF, Chang WT, Huang WC, Teng CF, Lin YS. Ceramide induces p38 MAPK and JNK activation through a mechanism involving a thioredoxin- interacting protein-mediated pathway. Blood. 2008; 1118: 4365-4374.
51. Westwick JK, Bielawska AE, Dbaibo G, Hannun YA, Brenner DA. Ceramide activates the stress-activated protein kinases. J Biol Chem. 1995; 27039: 22689-22692.
52. Welsh N. Interleukin-1-induced ceramide and diacylglycerol generation may lead to activation of the c-Jun NH2-terminal kinase and the transcription factor ATF2 in the insulin-producing cell line RINm5F. J Biol Chem. 1996; 27114: 8307-8312.
53. Masamune A, Igarashi Y, Hakomori S. Regulatory role of ceramide in interleukin IL-1-induced E-selectin expression in human umbilical vein endothelial cells. Ceramide enhances IL-1-action, but is not sufficient for E-selectin expression. J Biol Chem. 1996; 27116: 9368-9375.
54. Davis CN, Tabarean I, Gaidarova S, Behrens MM, Bartfai T. IL-1-induces aMyD88-dependent and ceramide-mediated activation of Src in anterior hypothalamic neurons. J Neurochem. 2006; 985: 1379-1389.
55. Carracedo A, Lorente M, Egia A, Blazquez C, Garcia S, Giroux V, et al. The stress-regulated protein p8 mediates cannabinoid-induced apoptosis of tumor cells. Cancer Cell. 2006; 94: 301-312.
56. Grullich C, Sullards MC, Fuks Z, Merrill Jr AH, Kolesnick R. CD95Fas/APO-1 signals ceramide generation indepen dent of the effector stage of apoptosis. J Biol Chem. 2000; 27512: 8650-8656.
57. Schutze S, Schneider-Brachert W. Impact of TNF-R1 and CD95 internalization on apoptotic and antiapoptotic signaling. Results Probl Cell Differ. 2009; 49: 63-85.
58. Segui B, Legembre P. Redistribution of CD95 into the lipid rafts to treat cancer cells? Recent Pat Anticancer Drug Discov. 2010; 51: 22-28.
59. Tepper AD, Ruurs P,Wiedmer T, Sims PJ, Borst J, van Blitterswijk WJ. Sphingomyelin hydrolysis to ceramide during the execution phase of apoptosis results from phospholipid scrambling and alters cell-surface morphology. J Cell Biol. 2000; 1501: 155-164.
60. Tepper AD, Cock JG, de Vries E, Borst J, van Blitterswijk WJ. CD95/Fas-induced ceramide formation proceeds with slow kinetics and is not blocked by caspase-3/CPP32 inhibition. J Biol Chem. 1997; 27239: 24308-24312.
61. Tepper AD, Vriesde E, Blitterswijkvan WJ, Borst J. Ordering of ceramide formation, caspase activation, and mitochondrial changes during CD95-and DNA damageinduced apoptosis. J Clin Invest. 1999; 1037: 971-978.
62. Major CD, Gao ZY, Wolf BA. Activation of the sphingomyelinase/ceramide signal transduction pathway in insulin-secreting-cells: Role in cytokine-induced-cell death. Diabetes. 1999; 487: 1372-1380.
63. Frago LM, LeonY, Rosadela EJ, Gomez-Munoz A,Varela-Nieto I. Nerve growth factor and ceramides modulate cell death in the early developing inner ear. J Cell Sci. 1998; 111 Pt 5: 549-556.
64. Flores I, Martinez AC, Hannun YA, Merida I. Dual role of ceramide in the control of apoptosis following IL-2 withdrawal. J Immunol. 1998; 1607: 3528-3533.
65. Guenther GG, Peralta ER, Rosales KR, Wong SY, Siskind LJ, Edinger AL. Ceramide starves cells to death by downregulating nutrient transporter proteins. Proc Natl Acad Sci USA. 2008; 10545: 17402-17407.
66. Mielke MM, Bandaru VV, Haughey NJ, Xia J, Fried LP, Yasar S, et al. Serum ceramides increase the risk of Alzheimer disease: The Women's Health and Aging Study II. Neurology. 2012; 797: 633-641.
67. Haughey NJ, Cutler RG, Tamara A, McArthur JC, Vargas DL, Pardo CA, et al. Perturbation of sphingolipid metabolism and ceramide production in HIV-dementia. Ann Neurol. 2004; 552: 257-267.
68. Satoi H, Tomimoto H, Ohtani R, Kitano T, Kondo T, Watanabe M, et al. Astroglial expression of ceramide in Alzheimer's disease brains: A role during neuronal apoptosis. Neuroscience. 2005; 1303: 657-666.
69. Han X,DMH,McKeel Jr DW,Kelley J,Morris JC. Substantial sulfatide deficiency and ceramide elevation in very early Alzheimer's disease: Potential role in disease pathogenesis. J Neurochem. 2002; 824: 809-818.
70. McCoy MK, Martinez TN, Ruhn KA, Szymkowski DE, Smith CG, Botterman BR, et al. Blocking soluble tumor necrosis factor signaling with dominant-negative tumor necrosis factor inhibitor attenuates loss of dopaminergic neurons in models of Parkinson's disease. J Neurosci. 2006; 2637: 9365-9375.
71. Barber SA, Detore G, McNally R, Vogel SN. Stimulation of the ceramide pathway partially mimics lipopolysaccharideinduced responses in murine peritoneal macrophages. Infect Immun. 1996; 648: 3397-3400.
72. Chae HJ, Chae SW, Kang JS, Bang BG, Cho SB, Park RK, et al. Dexamethasone suppresses tumor necrosis factor-induced apoptosis in osteoblasts: Possible role for ceramide. Endocrinology. 2000; 1418: 2904-2913.
73. Yasuo M, Mizuno S, Allegood J, Kraskauskas D, Bogaard HJ, Spiegel S, et al. Fenretinide causes emphysema, which is prevented by sphingosine 1-phoshate. PLoS One. 2013; 81: e53927.
74. Gills JJ, Zhang C, Abu-Asab MS, Castillo SS, Marceau C, LoPiccolo J, et al. Ceramide mediates nanovesicle shedding and cell death in response to phosphatidylinositol ether lipid analogs and perifosine. Cell Death Dis. 2012; 3: e340.
75. Stoica BA, Movsesyan VA, Lea PMT, Faden AI. Ceramide-induced neuronal apoptosis is associated with dephosphorylation of Akt, BAD, FKHR, GSK-3-, and induction of the mitochondrial-dependent intrinsic caspase pathway. Mol Cell Neurosci. 2003; 223: 365-382.
76. Petrache I, Petrusca DN, Bowler RP, Kamocki K. Involvement of ceramide in cell death responses in the pulmonary circulation. Proc Am Thorac Soc. 2011; 86: 492-496.
77. Petrache I, Natarajan V, Zhen L, Medler TR, Richter AT, Cho C, et al. Ceramide upregulation causes pulmonary cell apoptosis and emphysema-like disease in mice. Nat Med. 2005; 115: 491-498.
78. Chan C, Goldkorn T. Ceramide path in human lung cell death. Am J Respir Cell Mol Biol. 2000; 224: 460-468.
79. Bismuth J, Lin P, Yao Q, Chen C. Ceramide: A common pathway for atherosclerosis? Atherosclerosis. 2008; 1962: 497-504.
80. Schissel SL, Tweedie-Hardman J, Rapp JH, Graham G, Williams KJ, Tabas I. Rabbit aorta and human atherosclerotic lesions hydrolyze the sphingomyelin of retained low-density lipoprotein. Proposed role for arterial-wall sphingomyelinase in subendothelial retention and aggregation of atherogenic lipoproteins. J Clin Invest. 1996; 986: 1455-1464.
81. NakashimaY,Wight TN, Sueishi K. Early atherosclerosis in humans: Role of diffuse intimal thickening and extracellular matrix proteoglycans. Cardiovasc Res. 2008; 791: 14-23.
82. Fok PW. Growth of necrotic cores in atherosclerotic plaque. Math Med Biol. 2012; 294: 301-327.
83. Xu XX, Tabas I. Sphingomyelinase enhances low density lipoprotein uptake and ability to induce cholesteryl ester accumulation in macrophages. J Biol Chem. 1991; 26636: 24849-24858.
84. Kolesnick RN. Sphingomyelin and derivatives as cellular signals. Prog Lipid Res. 1991; 301: 1-38.
85. Spiegel S, Merrill Jr AH. Sphingolipid metabolism and cell growth regulation. FASEB J. 1996; 1012: 1388-1397.
86. Merrill Jr AH, Schmelz EM, Dillehay DL, Spiegel S, Shayman JA, Schroeder JJ, et al. Sphingolipids-the enigmatic lipid class: Biochemistry, physiology, and pathophysiology. Toxicol Appl Pharmacol. 1997; 1421: 208-225.
87. Deevska GM, Sunkara M, Morris AJ, Nikolova-Karakashian MN. Characterization of secretory sphingomyelinase activity: Lipoprotein sphingolipid content and LDL aggregation in ldlr-/-mice fed on a high-fat diet. Biosci Rep. 2012; 325: 479-490.
88. Ichi I, Nakahara K, Kiso K, Kojo S. Effect of dietary cholesterol and high fat on ceramide concentration in rat tissues. Nutrition. 2007; 237-8: 570-574.
89. Grandl M, Bared SM, Liebisch G, Werner T, Barlage S, Schmitz G. E-LDL and Ox-LDL differentially regulate ceramide and cholesterol raft microdomains in human Macrophages. Cytometry A. 2006; 693: 189-191.
90. Boyanovsky B, Karakashian A, King K, Giltiay N, Nikolova-Karakashian M. Uptake and metabolism of low density lipoproteins with elevated ceramide content by human microvascular endothelial cells: Implications for the regulation of apoptosis. J Biol Chem. 2003; 27829: 26992-26999.
91. Kinscherf R, Claus R, Wagner M, Gehrke C, Kamencic H, Hou D, et al. Apoptosis caused by oxidized LDL is manganese superoxide dismutase and p53 dependent. FASEB J. 1998; 126: 461-467.
92. Dbaibo GS, Pushkareva MY, Rachid RA, Alter N, Smyth MJ, Obeid LM, et al. p53-dependent ceramide response to genotoxic stress. J Clin Invest. 1998; 1022: 329-339.
93. Kim SS, Chae HS, Bach JH, Lee MW, Kim KY, Lee WB, et al. P53 mediates ceramide-induced apoptosis in SKN-SH cells. Oncogene. 2002; 2113: 2020-2028.
94. Deng X, Gao F, May WS. Protein phosphatase 2A inactivates Bcl2's antiapoptotic function by dephosphorylation and up-regulation of Bcl2-p53 binding. Blood. 2009; 1132: 422-428.
95. Renert AF, Leprince P, Dieu M, Renaut J, Raes M, Bours V, et al. The proapoptotic C16-ceramide-dependent pathway requires the death-promoting factor Btf in colon adenocarcinoma cells. J Proteome Res. 2009; 810: 4810-4822.
96. Pruschy M, Resch H, Shi YQ, Aalame N, Glanzmann C, Bodis S. Ceramide triggers p53-dependent apoptosis in genetically defined fibrosarcoma tumour cells. Br J Cancer. 1999; 805-6: 693-698.
97. Willaime S, Vanhoutte P, Caboche J, Lemaigre-Dubreuil Y, Mariani J, Brugg B. Ceramide-induced apoptosis in cortical neurons is mediated by an increase in p38 phosphorylation and not by the decrease in ERK phosphorylation. Eur J Neurosci. 2001; 1311: 2037-2046.
98. Xu J, Yeh CH, Chen S, He L, Sensi SL, Canzoniero LM, et al. Involvement of de novo ceramide biosynthesis in tumor necrosis factor-alpha/cycloheximide- induced cerebral endothelial cell death. J Biol Chem. 1998; 27326: 16521-16526.
99. Modur V, Zimmerman GA, Prescott SM, McIntyre TM. Endothelial cell inflammatory responses to tumor necrosis factor-. Ceramide-dependent and-independent mitogenactivated protein kinase cascades. J Biol Chem. 1996; 27122: 13094-13102.
100. Petrache I, Medler TR, RichterAT, Kamocki K, Chukwueke U, Zhen L, et al. Superoxide dismutase protects against apoptosis and alveolar enlargement induced by ceramide. Am J Physiol Lung Cell Mol Physiol. 2008; 2951: L44-L53.
101. Yorek MA, Dunlap JA, Thomas MJ, Cammarata PR, Zhou C, Lowe Jr WL. Effect of TNF-on SMITmRNAlevels and myo-inositol accumulation in cultured endothelial cells.Am J Physiol. 1998; 2741 Pt 1: C58-71.
102. Xu J, Yeh CH, Chen S, He L, Sensi SL, Canzoniero LM, et al. Involvement of de novo ceramide biosynthesis in tumor necrosis factor-/cycloheximide-induced cerebral endothelial cell death. J Biol Chem. 1998; 27326: 16521-16526.
103. Soeda S, Tsunoda T, Kurokawa Y, Shimeno H. Tumor necrosis factor-induced release of plasminogen activator inhibitor-1 from human umbilical vein endothelial cells: Involvement of intracellular ceramide signaling event. Biochim Biophys Acta. 1998; 14481: 37-45.
104. Johns DG, Webb RC. TNF-induced endotheliumindependent vasodilation: A role for phospholipase A2-dependent ceramide signaling. Am J Physiol. 1998; 2755 Pt 2: H1592-H1598.
105. Bhagat K, Vallance P. Inflammatory cytokines impair endothelium-dependent dilatation in human veins in vivo. Circulation. 1997; 969: 3042-3047.
106. Nakamura M, Yoshida H, Arakawa N, Saitoh S, Satoh M, Hiramori K. Effects of tumor necrosis factor-on basal and stimulated endothelium-dependent vasomotion in human resistance vessel. J Cardiovasc Pharmacol. 2000; 364: 487-492.
107. Wang P, Ba ZF, Chaudry IH. Administration of tumor necrosis factor-in vivo depresses endothelium-dependent relaxation. Am J Physiol. 1994; 2666 Pt 2: H2535-2541.
108. Sawada M, Kiyono T, Nakashima S, Shinoda J, Naganawa T, Hara S, et al. Molecular mechanisms of TNF-induced ceramide formation in human glioma cells: P53-mediated oxidant stress-dependent and-independent pathways. Cell Death Differ. 2004; 119: 997-1008.
109. Singh I, Pahan K, Khan M, Singh AK. Cytokine-mediated induction of ceramide production is redox-sensitive. Implications to proinflammatory cytokine-mediated apoptosis in demyelinating diseases. J Biol Chem. 1998; 27332: 20354-20362.
110. Garcia-Ruiz C, Colell A, Mari M, Morales A, Fernandez-Checa JC. Direct effect of ceramide on the mitochondrial electron transport chain leads to generation of reactive oxygen species. Role of mitochondrial glutathione. J Biol Chem. 1997; 27217: 11369-11377.
111. Haimovitz-Friedman A, Kan CC, Ehleiter D, Persaud RS, McLoughlin M, Fuks Z, et al. Ionizing radiation acts on cellular membranes to generate ceramide and initiate apoptosis. J Exp Med. 1994; 1802: 525-535.
112. Rotolo JA, Zhang J, Donepudi M, Lee H, Fuks Z, Kolesnick R. Caspase-dependent and-independent activation of acid sphingomyelinase signaling. J Biol Chem. 2005; 28028: 26425-26434.
113. Barth BM, Cabot MC, Kester M. Ceramide-based therapeutics for the treatment of cancer. Anticancer Agents Med Chem. 2011; 119: 911-919.